🔎 Trials Near Me

Home › Seizures › Texas › Houston

Seizures clinical trials in Houston, TX

7 studies for Seizures are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

RecruitingPhase 3
  • UTHealth Houston, Houston
Ages 2 to 55 · All sexes · Updated Sep 15, 2026 · NCT05066217

Prospective Natural History Study of POLG Disease

RecruitingObservational study
  • UTHealth Houston, Houston
All ages · All sexes · Updated Sep 15, 2026 · NCT07775872

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

RecruitingPhase 3
  • Baylor College of Medicine, Houston
  • University of Texas Health Science Center in Houston, Houston
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119

Mapping of Human Cognition

Recruiting
  • The University of Texas Health Science Center at Houston, Houston
Ages 18 to 75 · All sexes · Updated Jul 14, 2026 · NCT05989893

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

RecruitingPhase 3
  • UTHealth Houston, Houston
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

RecruitingPhase 2
  • Baylor College of Medicine, Houston
Ages 18 to 70 · All sexes · Updated Jan 23, 2026 · NCT07219407

Pediatric Dose Optimization for Seizures in Emergency Medical Services

RecruitingPhase 3
  • Baylor College of Medicine, Houston
6 Months – 13 Years · All sexes · Updated Sep 30, 2025 · NCT05121324

About Seizures

Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.

More about Seizures on MedlinePlus

Seizures trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.